Schedule 13D ownership disclosure

Amneal Pharmaceuticals Inc

Class A Common Stock, par value $0.01 · CUSIP: 03168L105

Event date: 2025-08-06

Filing-level shares
22,180,421
Percent of class
7.1%
  • Patel Chirag K.Reported CIK 0001738701

    Shares: 22,180,421 · Class: 7.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000898432-25-000584
Form type
SCHEDULE 13D/A
Filer
Amneal Pharmaceuticals, Inc.
CIK
CIK 1723128
Filed
Aug 08, 2025
Reporting period
Aug 06, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub